TEM: Robust growth in diagnostics and data, fueled by AI and regulatory wins, drives strong outlook
Strong diagnostic and data licensing growth, driven by robust demand, FDA approvals, and AI adoption, supports a confident outlook for 25%+ annual growth. Strategic acquisitions and partnerships, especially in MRD and vaccine sequencing, further enhance revenue potential and market positioning.Base…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.